Summary
A Phase IV, randomized, single-blind, placebo-controlled, multi-center study to evaluate the immunogenicity of pneumococcal and influenza vaccines in adult subjects with rheumatoid arthritis receiving Study Drug or placebo.
Register to download
Persistence Leads To High Enrollment
You may also be interested in:
Case Study
PRA Delivers Study Start-up Success
PRA was awarded a rheumatoid arthritis study contract based on our strategy for achieving first-patient-in (FPI) by the end of the calendar year.…
View Resource
Blog
Ask the Experts Roundtable: Insights on Pfizer and Moderna’s Recent mRNA-Based Vaccine Developments
As the COVID-19 pandemic continues to challenge humankind worldwide, the medical industry and professionals alike are developing vaccines at…
Read Story
Case Study
Targeting Patients In A Complex Phase II Rheumatoid Arthritis Study
Targeting Patients In A Complex Phase IIa Rheumatoid Arthritis Study.
View Resource
View all related content and resources for Immunology
Explore Insights